Sandoz Group (OTCMKTS:SDZNY) Lowered to Hold Rating by UBS Group

UBS Group downgraded shares of Sandoz Group (OTCMKTS:SDZNY) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

Separately, BNP Paribas lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.

Sandoz Group Stock Performance

Shares of SDZNY opened at $48.61 on Monday. Sandoz Group has a 12 month low of $27.79 and a 12 month high of $48.66. The stock has a fifty day moving average price of $43.52 and a 200 day moving average price of $43.20.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.